Method for killing HIV-infected cells using Bcl-2 inhibitors Grant US-11938098-B2 United States of America 26 Mar 2024
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11732051-B2 United States of America 22 Aug 2023
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia Grant US-11713355-B2 United States of America 01 Aug 2023
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11708419-B2 United States of America 25 Jul 2023
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11708420-B2 United States of America 25 Jul 2023
Methods of treating high risk multiple myeloma Grant US-11618787-B2 United States of America 04 Apr 2023
ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS Application US-20230087443-A1 United States of America 23 Mar 2023
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11566079-B2 United States of America 31 Jan 2023
Methods and materials for treating human immunodeficiency virus infections Grant US-11376268-B2 United States of America 05 Jul 2022
Immune modulation and treatment of solid tumors with antibodies that specifically bind… Grant US-11021543-B2 United States of America 01 Jun 2021
Combination therapies with anti-CD38 antibodies Grant US-10800851-B2 United States of America 13 Oct 2020
Anti-CD38 antibodies for treatment of acute myeloid leukemia Grant US-10793630-B2 United States of America 06 Oct 2020
Methods and materials for treating human immunodeficiency virus infections Grant US-10786519-B2 United States of America 29 Sep 2020
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-10781261-B2 United States of America 22 Sep 2020
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive… Grant US-10766965-B2 United States of America 08 Sep 2020
Combination therapies for heme malignancies with anti-CD38 antibodies and survivin… Grant US-10668149-B2 United States of America 02 Jun 2020
Combination therapies with anti-CD38 antibodies Grant US-10604580-B2 United States of America 31 Mar 2020
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia Grant US-10556961-B2 United States of America 11 Feb 2020
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-10385135-B2 United States of America 20 Aug 2019